Arbor Wealth Management’s Gilead Sciences GILD Stock Holding History

Arbor Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-800	Closed	-$50K	–	206
2018 Q4	$50K	Buy	+800	New	+$55.9K	0.04%	75
2017 Q3	–	Sell	-34,203	Closed	-$2.48M	–	65
2017 Q2	$2.48M	Buy	34,203 +467	+1%	+$31.1K	2.34%	19
2017 Q1	$2.23M	Buy	33,736 +697	+2%	+$49K	1.96%	22
2016 Q4	$2.22K	Sell	33,039 -74	-0.2%	-$5.5K	1.73%	24
2016 Q3	$2.41M	Buy	33,113 +1,280	+4%	+$104K	2.05%	19
2016 Q2	$2.55M	Buy	31,833 +27,406	+619%	+$2.43M	2.41%	16
2016 Q1	$378K	Buy	4,427 +3,776	+580%	+$341K	0.39%	55
2015 Q4	$55K	Buy	+651	New	+$67.7K	0.06%	101

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arbor Wealth Management's GILD Position: Q1 2019 in Review

Arbor Wealth Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 800 shares — an estimated $50K sold.

Arbor Wealth Management first reported a position in GILD in Q4 2015 and held it in 8 quarters. The position peaked at $2.55M in Q2 2016. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Arbor Wealth Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Arbor Wealth Management sold 800 Gilead Sciences shares in Q1 2019, an estimated $50K.
Arbor Wealth Management first reported a position in Gilead Sciences in Q4 2015 and held it in 8 quarters.
Arbor Wealth Management's Gilead Sciences position peaked at $2.55M in Q2 2016.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Arbor Wealth Management's 13F filing for Q1 2019, filed 15 May 2019.